Latest filing published 04 May 2021 for Werewolf Therapeutics, Inc., €4.2M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Sakae Asanuma: trading record in brief
All filings by Sakae Asanuma on record concern Werewolf Therapeutics, Inc. The record holds 3 filings, all for trades on 4 May 2021.
Purchases make up the whole of the open-market record (1 purchase, €4.2M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Most recently, on 4 May 2021, the filings show an open-market purchase worth €4.2M in Werewolf Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sakae Asanuma
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 312,500 shares@ US$16.00100.0% of flowCommon StockSEC:0000899243-21-018116:2Canonical exit: 2 Aug 2021 (T+90)
- 438,098 sharesCommon StockSEC:0000899243-21-018116:1
- 1,318,311 sharesCommon StockSEC:0000899243-21-018116:0
3 of 2 declarations
